Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.26
Delayed Data
As of Feb 11
 0.00 / 0.00%
Today’s Change
0.82
Today|||52-Week Range
2.87
-10.64%
Year-to-Date

Today’s Trading

Previous close1.26
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)8,022
Market cap$15.0M
Dividend yield--
Data as of 02/11/2016

Growth & Valuation

Earnings growth (last year)+1.68%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book3.12

Competitors

 Today’s
change
Today’s
% change
BVXVBiondVax Pharmaceuti...+0.02+0.51%
EVOKEvoke Pharma Inc+0.07+2.55%
ATOSAtossa Genetics Inc+0.10+44.19%
CYANCyanotech Corp+0.23+5.94%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 17, 2016
EPS forecast (this quarter)$0.00
Annual revenue (last year)$0.00
Annual profit (last year)-$2.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts

Partner Offers